SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
102.50
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
In the year 2024, SYN-TECH Chem. & Pharm. had annual revenue of 1.26B TWD with 12.83% growth. SYN-TECH Chem. & Pharm. had revenue of 314.27M in the quarter ending December 31, 2024, with 15.59% growth.
Revenue
1.26B
Revenue Growth
+12.83%
P/S Ratio
3.63
Revenue / Employee
5.54M
Employees
227
Market Cap
4.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Polaris Group | 107.00M |
Pegavision | 6.82B |